Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Clinical Rheumatology
|
March 9, 2026
Global patterns and predictors of initial treatment in early rheumatoid arthritis: insights from a multinational machine learning study
David Vega-Morales, Pedro Machado, Sytske Anne Bergstra, et al.
Arthritis Care & Research
|
March 2, 2019
Impact of Patient's Global Assessment on Achieving Remission in Patients With Rheumatoid Arthritis: A Multinational Study Using the METEOR Database
Ricardo J O Ferreira, Pedro David Carvalho, Mwidimi Ndosi, et al.
International Journal of Rheumatic Diseases
|
August 10, 2021
Rheumatoid arthritis management in the APLAR region: Perspectives from an expert panel of rheumatologists, patients and community oriented program for control of rheumatic diseases
Arvind Chopra, Hsiao-Yi Lin, Sandra V Navarra, et al.
The Journal of Rheumatology
|
May 3, 2019
Association of 17 Definitions of Remission with Functional Status in a Large Clinical Practice Cohort of Patients with Rheumatoid Arthritis
Pedro D Carvalho, Ricardo J O Ferreira, Robert Landewé, et al.
Clinical Rheumatology
|
June 8, 2015
Itolizumab in combination with methotrexate modulates active rheumatoid arthritis: safety and efficacy from a phase 2, randomized, open-label, parallel-group, dose-ranging study
Arvind Chopra, S Chandrashekara, Rajgopalan Iyer, et al.
International Journal of Rheumatic Diseases
|
June 2, 2020
Tofacitinib in the treatment of Indian patients with rheumatoid arthritis: A post hoc analysis of efficacy and safety in Phase 3 and long-term extension studies over 7 years
Arvind Chopra, Vineeta Shobha, Srikantiah Chandrashekara, et al.
Plos One
|
March 17, 2023
Co-administration of AYUSH 64 as an adjunct to standard of care in mild and moderate COVID-19: A randomized, controlled, multicentric clinical trial
Arvind Chopra, Girish Tillu, Kuldeep Chuadhary, et al.
Seminars in Arthritis and Rheumatism
|
April 17, 2025
Rheumatoid arthritis-associated interstitial lung disease in countries across the world
Sascha L Heckert, Tjardo D Maarseveen, Emiel R Marges, et al.
International Journal of Rheumatic Diseases
|
March 7, 2025
Burden of Musculoskeletal (MSK) Pain and Arthritis in India: A Community Oriented Program for Control of Rheumatic Diseases (COPCORD-Bone and Joint Decade (BJD)) India Project
Arvind Chopra, Ashish Jacob Mathew, Rohini Handa, et al.
Annals of the Rheumatic Diseases
|
January 16, 2021
Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial
René Westhovens, William F C Rigby, Désirée van der Heijde, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Clinical Rheumatology
|
March 9, 2026
Global patterns and predictors of initial treatment in early rheumatoid arthritis: insights from a multinational machine learning study
David Vega-Morales, Pedro Machado, Sytske Anne Bergstra, et al.
Arthritis Care & Research
|
March 2, 2019
Impact of Patient's Global Assessment on Achieving Remission in Patients With Rheumatoid Arthritis: A Multinational Study Using the METEOR Database
Ricardo J O Ferreira, Pedro David Carvalho, Mwidimi Ndosi, et al.
International Journal of Rheumatic Diseases
|
August 10, 2021
Rheumatoid arthritis management in the APLAR region: Perspectives from an expert panel of rheumatologists, patients and community oriented program for control of rheumatic diseases
Arvind Chopra, Hsiao-Yi Lin, Sandra V Navarra, et al.
The Journal of Rheumatology
|
May 3, 2019
Association of 17 Definitions of Remission with Functional Status in a Large Clinical Practice Cohort of Patients with Rheumatoid Arthritis
Pedro D Carvalho, Ricardo J O Ferreira, Robert Landewé, et al.
Clinical Rheumatology
|
June 8, 2015
Itolizumab in combination with methotrexate modulates active rheumatoid arthritis: safety and efficacy from a phase 2, randomized, open-label, parallel-group, dose-ranging study
Arvind Chopra, S Chandrashekara, Rajgopalan Iyer, et al.
International Journal of Rheumatic Diseases
|
June 2, 2020
Tofacitinib in the treatment of Indian patients with rheumatoid arthritis: A post hoc analysis of efficacy and safety in Phase 3 and long-term extension studies over 7 years
Arvind Chopra, Vineeta Shobha, Srikantiah Chandrashekara, et al.
Plos One
|
March 17, 2023
Co-administration of AYUSH 64 as an adjunct to standard of care in mild and moderate COVID-19: A randomized, controlled, multicentric clinical trial
Arvind Chopra, Girish Tillu, Kuldeep Chuadhary, et al.
Seminars in Arthritis and Rheumatism
|
April 17, 2025
Rheumatoid arthritis-associated interstitial lung disease in countries across the world
Sascha L Heckert, Tjardo D Maarseveen, Emiel R Marges, et al.
International Journal of Rheumatic Diseases
|
March 7, 2025
Burden of Musculoskeletal (MSK) Pain and Arthritis in India: A Community Oriented Program for Control of Rheumatic Diseases (COPCORD-Bone and Joint Decade (BJD)) India Project
Arvind Chopra, Ashish Jacob Mathew, Rohini Handa, et al.
Annals of the Rheumatic Diseases
|
January 16, 2021
Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial
René Westhovens, William F C Rigby, Désirée van der Heijde, et al.
Page
of 9